As of Oct 02
| +2.84 / +3.09%|
The 6 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 113.00, with a high estimate of 134.00 and a low estimate of 92.00. The median estimate represents a +19.14% increase from the last price of 94.85.
The current consensus among 6 polled investment analysts is to Buy stock in Clovis Oncology Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.